Role of matrix metalloproteinase-9 (MMP-9) in striatal blood-brain barrier disruption in a 3-nitropropionic acid model of Huntington's disease

Matrix metalloproteinases and their multiple roles in neurodegenerative diseases

(2009) Gary A Rosenberg   LANCET NEUROLOGY

Distinct neuroinflammatory profile in post-mortem human Huntingtonʼs disease

(2009) Aurelio Silvestroni et al.   NEUROREPORT

Mechanisms of neurodegeneration in Huntington’s disease

(2008) Joana M. Gil et al.   EUROPEAN JOURNAL OF NEUROSCIENCE

Dopamine determines the vulnerability of striatal neurons to the N-terminal fragment of mutant huntingtin through the regulation of mitochondrial complex II

(2008) Alexandra Benchoua et al.   HUMAN MOLECULAR GENETICS

Induction of MMP-9 Expression and Endothelial Injury by Oxidative Stress after Spinal Cord Injury

(2008) Fengshan Yu et al.   JOURNAL OF NEUROTRAUMA

The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders

(2008) Berislav V. Zlokovic   NEURON

Blood-brain barrier disruption in the striatum of rats treated with 3-nitropropionic acid

(2008) Joaquim Duran-Vilaregut et al.   NEUROTOXICOLOGY